Effect of terbutaline, a beta 2-adrenergic receptor stimulating compound, on cutaneous reponses to histamine, allergen, compound 48/80, and trypsin.
The beta-adrenoceptor stimulating agent terbutaline (2 ng-2 microgram) injected intradermally in eight atopic subjects produced a dose-dependent inhibition of the skin reactions induced by subsequently injected allergen. After injection of 0.5 microgram terbutaline inhibition of the flare and weal responses was demonstrable throughout the observation period of 90 min. The flare response induced by histamine, the histamine liberator compound 48/80 and the proteolytic enzyme trypsin was not inhibited by terbutaline in the doses used, suggesting a selective action of terbutaline on the allergen-induced response. The weal response elicited by histamine and compound 48/80 was slightly reduced by 2 microgram terbutaline. It is suggested that pretreatment of the skin with terbutaline interferes with the ability of the cutaneous mast cells to respond to challenge with allergen and that terbutaline produces this effect in doses lower than those needed to counteract the permeability increasing effect of released mediator substances.
D000293:Adolescent; D000318:Adrenergic beta-Agonists; D000328:Adult; D000485:Allergens; D004306:Dose-Response Relationship, Immunologic; D006632:Histamine / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis* / Q000276:immunology; D007271:Injections, Intradermal; D012867:Skin / Q000187:drug effects* / Q000276:immunology; D013726:Terbutaline / Q000008:administration & dosage / Q000494:pharmacology*; D014357:Trypsin / Q000008:administration & dosage / Q000494:pharmacology*; D003189:p-Methoxy-N-methylphenethylamine / Q000008:administration & dosage / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000485:Allergens; D003189:p-Methoxy-N-methylphenethylamine; D006632:Histamine; D014357:Trypsin; D013726:Terbutaline